Literature DB >> 2148427

The induction of human B-cell activation, proliferation and differentiation by anti-CD3-stimulated T cells--a model of T cell/B cell collaboration.

P E Lipsky1.   

Abstract

It is clear that anti-CD3-activated T cells provide all the signals necessary for polyclonal activation, proliferation and differentiation of human B cells. B-cell activation, proliferation and differentiation are initiated by a complex series of receptor-ligand interactions, of which LFA-1-ICAM-1 ligation plays a central, but not exclusive role. In addition, the action of a number of cytokines, most prominently IL2, is essential for B-cell proliferation and differentiation. It is apparent from the results obtained using this model system that the conjugate formation that occurs as part of antigen presentation and T-cell activation is not required for the subsequent collaboration between activated T cells and B cells necessary to trigger B-cell responses. The implication of these studies is that after initial antigen recognition and T-cell activation, T cell/B cell collaboration leading to antibody production is antigen non-specific and potentially capable of inducing polyclonal B-cell responses. Conjugate formation that develops as part of antigen presentation may tend to focus the response and limit the B cells that can be induced to respond. Alternatively, T-cell recognition of antigen may deliver a signal to the B cell by cross-linking MHC molecules bearing the recognized antigenic fragment that makes it more capable of responding to the T-cell-derived antigen-non-specific signals and cytokines promoting B-cell activation, proliferation and differentiation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2148427     DOI: 10.1016/0923-2494(90)90034-v

Source DB:  PubMed          Journal:  Res Immunol        ISSN: 0923-2494


  3 in total

1.  In vitro synthesis of primary specific anti-breast cancer antibodies by normal human peripheral blood mononuclear cells.

Authors:  Archana Thakur; Oxana Norkina; Lawrence G Lum
Journal:  Cancer Immunol Immunother       Date:  2011-06-29       Impact factor: 6.968

2.  Exploring a peptide nucleic acid-based antisense approach for CD5 targeting in chronic lymphocytic leukemia.

Authors:  Elena Cesaro; Andrea Patrizia Falanga; Rosa Catapano; Francesca Greco; Simona Romano; Nicola Borbone; Arianna Pastore; Maria Marzano; Federico Chiurazzi; Stefano D'Errico; Gennaro Piccialli; Giorgia Oliviero; Paola Costanzo; Michela Grosso
Journal:  PLoS One       Date:  2022-03-31       Impact factor: 3.240

3.  Interleukin 10 (IL-10) upregulates functional high affinity IL-2 receptors on normal and leukemic B lymphocytes.

Authors:  A C Fluckiger; P Garrone; I Durand; J P Galizzi; J Banchereau
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.